Serum levels of epidermal growth factor and HER-2 neu in non small-cell lung cancer: Prognostic correlation

Medical Oncology

Volumn 26, Issue 2, 2009, Pages 161-166

  Abdel Salam, I ^a   Gaballa, H E ^a   Abdel Wahab, N ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

EGFR; HER 2 neu; NSCLC; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STANDARDIZATION; BLOOD; CHEMISTRY; LUNG TUMOR; MIDDLE AGED;

AGED; BRONCHOALVEOLAR LAVAGE FLUID; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 67651049950     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-008-9102-y     Document Type: Article

References (40)

1. P Richard, et al. 1996 Mortality from smoking worldwide Br Med Bull 25 12 21
2. PD Maxwell 2001 Global cancer statistics in the year 2000 Lancet Oncol 2 533 43 10.1016/S1470-2045(01)00486-7 10.1016/S1470-2045(01)00486-7 (Pubitemid 33586866)
3. G Sozzi, et al. 2003 Quantification of free circulating DNA as a diagnostic marker in lung cancer J Clin Oncol 21 3902 8 10.1200/JCO.2003.02.006 14507943 10.1200/JCO.2003.02.006 1:CAS:528:DC%2BD2cXpsVajsLk%3D (Pubitemid 46606202)
4. Y Yarden M Sliwkowski 2001 Untangling the ErbB signaling network Nat Rev Mol Cell Biol 2 127 37 10.1038/35052073 11252954 10.1038/35052073 1:CAS:528:DC%2BD3MXivVWnt7k%3D (Pubitemid 33674041)
5. MS Berger, et al. 1987 Epidermal growth factor receptors in lung tumors J Pathol 152 297 307 10.1002/path.1711520408 3668732 10.1002/path.1711520408 1:STN:280:DyaL1c%2FjsFCitg%3D%3D
6. F Ciardiello G Tortora 2001 A novel approach in the treatment of cancer: Targeting epidermal growth factor receptor Clin Cancer Res 7 2958 70 11595683 1:CAS:528:DC%2BD3MXnvF2ktbk%3D
7. CJ Piyathilake, et al. 2002 Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung Clin Cancer Res 8 734 44 11895903 1:CAS:528:DC%2BD38XislOqtLo%3D
8. F Lonardo, et al. 2002 Evidence of the epidermal growth factor receptor as a target for lung cancer prevention Clin Cancer Res 8 54 60 11801540 1:CAS:528:DC%2BD38XhsVKmt7Y%3D
9. T Akiyama, et al. 1986 The product of the human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity Science 232 1644 6 10.1126/science.3012781 3012781 10.1126/science.3012781 1:CAS:528: DyaL28XkvFahu7o%3D
10. N Hynes D Stern 1994 The biology of erbB-2/neu/HER-2 and its role in cancer Biochim Biophys Acta 1198 165 84 7819273
11. JR Zabrecky T Lam SJ McKenzie W Carney 1991 The extra cellular domain of p185/neu is released from the surface of human breast carcinoma cells SK-BR-3 J Biol Chem 266 1716 23 1671042 1:CAS:528:DyaK3MXhtF2nu7w%3D
12. B Breuer, et al. 1998 ErbB-2 protein in sera and tumors of breast cancer patients Breast Cancer Res Treat 49 261 70 10.1023/A:1006033214721 9776510 10.1023/A:1006033214721 1:CAS:528:DyaK1cXmvVSrurg%3D (Pubitemid 28416792)
13. PF Bongiorno, et al. 1994 Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas J Thorac Cardiovas Surg 107 590 5 1:STN:280:DyaK2c7jtlOmtw%3D%3D
14. Pw Brandt-Rauf MR Pincus WP Carney 1994 The c-erbB2 protein in oncogenesis: Molecular structure to molecular epidemiology Crit Rev Oncog 5 313 29 7849090 1:CAS:528:DyaK2MXis1Sntbw%3D
15. T Schondorf, et al. 2002 Serologic concentrations of HER-2/neu in breast cancer patients with visceral metastases receiving trastuzumab therapy predict the clinical course Clin Chem 48 8 1360 2 12142395 1:CAS:528: DC%2BD38XlslKkt7o%3D
16. LN Harris, et al. 2001 Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy J Clin Oncol 19 1698 706 11250999 1:CAS:528:DC%2BD3MXisFygs7w%3D
17. M Volm W Rittgen P Drings 1998 Prognostic value of erbB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas Br J Cancer 77 663 9 9484827 1:CAS:528:DyaK1cXksFKjur4%3D
18. Y Ohsaki, et al. 2000 Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 over expression Oncol Rep 7 603 7 10767376 1:CAS:528:DC%2BD3cXjtVOisr4%3D
19. G Cox JL Jones KJ O'Byrne 2000 Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non small cell lung Clin Cancer Res 6 2349 55 10873086 1:CAS:528:DC%2BD3cXksVGhsL4%3D
20. V Rusch, et al. 1997 Over expression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in respectable non small cell lung cancer but does not predict tumor progression Clin Cancer Res 3 515 22 9815714 1:CAS:528:DyaK2sXislGitLk%3D
21. G Fontanini, et al. 1998 Evaluation of epidermal growth factor related growth factors and receptors and of neo-angiogenesis in completely resected stage I-IIIA non small cell lung cancer Amphiregulin and micovessel count are independent prognostic indicators of survival Clin Cancer Res 4 241 9 9516978 1:STN:280:DyaK1c7nslKhsA%3D%3D
22. TM Greatens, et al. 1998 Do molecular markers predict survival in non small cell lung cancer? Am J Respir Crit Care Med 157 1093 7 9563724 1:STN:280:DyaK1c3itlaisQ%3D%3D
23. TA D'Amico, et al. 1999 A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers J Thorac Cardiovasc Surg 117 736 43 10.1016/S0022-5223(99)70294-1 10096969 10.1016/S0022-5223(99)70294-1
24. FR Hirsch, et al. 2003 Epidermal growth factor receptor in non small cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis J Clin Oncol 21 3798 807 10.1200/JCO.2003.11.069 12953099 10.1200/JCO.2003.11.069 1:CAS:528:DC%2BD2cXpsVKisL8%3D (Pubitemid 46606235)
25. H Nakamura, et al. 2006 Survival impact of epidermal growth factor receptor over expression in patients with non small cell lung cancer: a meta-analysis Thorax 61 140 5 10.1136/thx.2005.042275 16284218 10.1136/thx.2005.042275 1:STN:280:DC%2BD28%2FmtVWjug%3D%3D (Pubitemid 43235431)
26. F Cappuzzo, et al. 2007 EGFR and HER-2 gene copy number and response to first line chemotherapy in patients with advanced non small cell lung cancer (NSCLC) J Thorac Oncol 2 5 423 9 10.1097/01.JTO.0000268676.79872.9b 17473658 10.1097/01.JTO.0000268676.79872.9b (Pubitemid 47181697)
27. M Tateishi, et al. 1992 Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma Surg Oncol 49 209 12 10.1002/jso.2930490402 10.1002/jso.2930490402 1:STN:280:DyaK383htF2mug%3D%3D
28. T Mizutani, et al. 1993 Relationship of c-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer Cancer 72 2083 8 10.1002/1097-0142(19931001)72:7<2083::AID-CNCR2820720705>3.0.CO;2-1 8397058 10.1002/1097-0142(19931001)72:7<2083::AID-CNCR2820720705>3.0. CO;2-1 1:STN:280:DyaK3szos1KgsQ%3D%3D
29. JL Yang Y Yu B Markovic PJ Russel PJ Crowe 1997 Over expression of c-erb-2 mRNA and/or c-neu oncoprotein is a predictor for metastases from colorectal cancer Anticancer Res 17 2a 1023 6 9137444 1:STN:280: DyaK2s3otleisw%3D%3D
30. N Okada G Ohshio K Yamaki M Imamura 1995 Elevated serum c-erbB-2 protein levels in patients with pancreatic cancer: Correlation to metastasis and shorter survival Oncology 52 392 6 7637957 1:CAS:528:DyaK2MXoslSnurY%3D 10.1159/000227495
31. RB Myers D Brown DK Oelschlager JW Waterbor 1996 Elevated serum levels of p105(erbB-2) in patients with advanced-stage prostatic adenocarcinoma Int J Cancer 69 5 398 402 10.1002/(SICI)1097-0215(19961021)69:5<398::AID-IJC8>3. 0.CO;2-0 8900374 10.1002/(SICI)1097-0215(19961021)69:5<398::AID-IJC8>3.0. CO;2-0 1:CAS:528:DyaK28Xnt1KgtLo%3D (Pubitemid 26384110)
32. C Pellegrini, et al. 2003 HER-2/neu alternations in non small cell lung cancer: comprehensive evaluations by real time reverse transcription-PCR, fluorescence in situ hybridization and immunohistochemistry Clin Cancer Res 9 3645 52 14506153 1:CAS:528:DC%2BD3sXosVOlu7s%3D
33. U Gatzemiere, et al. 2004 Randomized phase II trial with gemcitabine and cisplatinum with or without trastuzumab in HER-2 positive NSCLC Ann Oncol 15 19 10.1093/annonc/mdh031 10.1093/annonc/mdh031 (Pubitemid 38139598)
34. D Tan, et al. 2003 HER-2/neu protein expression and gene alteration in stage I-IIIA non small cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization Diagn Mol Pathol 12 201 11 10.1097/00019606-200312000-00004 14639106 10.1097/00019606-200312000-00004 1:CAS:528:DC%2BD2cXkvFKhsA%3D%3D (Pubitemid 37475228)
35. H Nakamura, et al. 2005 Association of HER-2 over expression with prognosis in non small cell lung carcinoma: a meta-analysis Cancer 103 1865 73 10.1002/cncr.20957 15770690 10.1002/cncr.20957 1:CAS:528:DC%2BD2MXktFGnsbc%3D (Pubitemid 40563259)
36. Onn A, et al. Synchronous over expression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non small cell lung cancer. Clin Cancer Res. 2004;10(1 pt 1):136-43. doi: 10.1158/1078-0432.CCR-0373-3. (Pubitemid 38114172)
37. TW Jacobs, et al. 1999 Specificity of Hercep Test in determining HER-2/neu: status of breast cancer using the United States Food and Drug Administration approved scoring system J Clin Oncol 17 1983 7 10561248 1:CAS:528:DyaK1MXkvVSmtLg%3D
38. C Lovekin, et al. 1991 C-erbB-2 oncoprotein expression in primary and advanced breast cancer Br J Cancer 63 439 43 1672254 1:STN:280: DyaK3M7mslWrsA%3D%3D
39. G Pauletti, et al. 1996 Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization Oncogene 13 63 72 8700555 1:CAS:528:DyaK28Xks1ens74%3D
40. F Cappuzo, et al. 2005 Increased HER-2 gene copy number is associated with response to gefitinib therapy in EGFR-receptor positive NSCLC patients J Clin Oncol 23 22 5007 18 10.1200/JCO.2005.09.111 1:CAS:528:DC%2BD2MXpsFWmtLo%3D (Pubitemid 46224007)